BPCIA

BPCIA turns 10: Nearly 100 drugs become biologics
Endpoints
Tue, 03/24/20 - 10:41 am
BPCIA
biologics
FDA Finalizes ‘Biological Product’ Definition Ahead of BPCIA Transition
RAPS.org
Thu, 02/20/20 - 11:40 pm
FDA
biologics
BPCIA
FDA Rolls Out Expectations for Biosimilars, Soon-to-Be Biologics
RAPS.org
Wed, 12/12/18 - 12:17 am
FDA
biosimilars
biologics
BPCIA
The Demise of the BPCIA Patent Dance?
FDA Law Blog
Fri, 03/3/17 - 09:40 am
BPCIA
patents
Genentech
Amgen
Sandoz
Avastin
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
FDA Law Blog
Wed, 02/17/16 - 11:33 am
Sandoz
FDA
BPCIA
Amgen
Zarxio
Neupogen